KalVista Pharmaceuticals, Inc. (KALV)

15.84 +0.67 (+4.42%) USD  |  NASDAQ  |  Dec 30, 14:42
More

KalVista Pharmaceuticals EPS Basic from Accounting Change (Quarterly)

EPS Basic from Accounting Change (Quarterly) Chart

View EPS Basic from Accounting Change (Quarterly) for KALV.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View EPS Basic from Accounting Change (Quarterly) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

EPS Basic from Accounting Change (Quarterly) Range, Past 5 Years

View EPS Basic from Accounting Change (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

EPS Basic from Accounting Change (Quarterly) Benchmarks

View EPS Basic from Accounting Change (Quarterly) Benchmarks
Start Trial
BioCryst Pharmaceuticals, Inc. --
Silvergate Capital Corp. --
Perspective Therapeutics, Inc. --
Electromed, Inc. --
Xtant Medical Holdings, Inc. --